Skip to main content

Cytokinetics Inc

CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001061983

In the last 90 days, Cytokinetics Inc insiders filed 0 open-market purchases and 19 sales; 481 institutions reported holding it in 13F filings for Q2 2026, worth $13.7B in total; no superinvestor holds it.

Superinvestors holding CYTK, Q2 2026

See all superinvestors

No superinvestor reported holding CYTK in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of CYTK each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q3 2021

    0 superinvestors holding at quarter end

    Sold out
    HHLR Advisors (Hillhouse)